C vs INCY · P/E 16, rev $85.22B vs P/E 14, rev $5.14B
Citigroup Inc. (C) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
C currently screens at market cap $214.73B and trailing P/E 15.5. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the C and INCY stock pages for the full models.
Not investment advice.